| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $22.69M | - | |
| Other | 52.8K | $8.53M | - | |
| Other | 46.8K | $7.56M | - | |
| Other | 39.6K | $6.41M | -36,937 | |
| Other | 36.8K | $5.96M | -22,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 17, 2024 | Sharp Shalini | Director | Sale+OE | 1,106 | $141.90 | $156,943.39 | -52.7% | +3.9% | -14.9% | |
| May 17, 2024 | Pops Richard F57 | Director | Sale+OE | 2,100 | $141.84 | $297,860.43 | -6.2% | +3.9% | -14.9% | |
| May 17, 2024 | Norwalk Leslie V64 | Director | Sale+OE | 1,106 | $141.82 | $156,849.93 | -52.7% | +3.9% | -14.9% | |
| May 15, 2024 | Abernethy Matt57 | Chief Financial Officer | Sale+OE | 30,000 | $137.95 | $4,138,435.50 | -32.2% | +6.1% | -15.3% | |
| May 14, 2024 | Lyons Gary A54 | Director | Sale+OE | 12,500 | $135.63 | $1,695,370.00 | -9.7% | +6.4% | -14.2% | |
| May 6, 2024 | Delaet Ingrid67 | Chief Regulatory Officer | Sale+OE | 273 | $140.55 | $38,370.15 | -3.5% | +4.2% | -16.1% | |
| Apr 15, 2024 | Benevich Eric62 | Chief Commercial Officer | Sale+OE | 19,818 | $133.36 | $2,643,019.64 | -19.5% | +11.9% | -27.0% | |
| Apr 1, 2024 | Delaet Ingrid67 | Chief Regulatory Officer | Sale+OE | 272 | $137.30 | $37,345.60 | -3.5% | -0.9% | -24.3% | |
| Mar 21, 2024 | Delaet Ingrid67 | Chief Regulatory Officer | Sale+OE | 5,000 | $145.06 | $725,320.00 | -40.0% | -6.7% | -22.1% | |
| Mar 14, 2024 | Benevich Eric62 | Chief Commercial Officer | Sale+OE | 75,000 | $139.38 | $10,453,417.50 | -47.9% | -3.3% | -20.4% |